Intrommune Therapeutics is a startup based in the United States.
Based in the United States, Intrommune Therapeutics is a startup.
Intrommune Therapeutics develops toothpaste-based oral mucosal immunotherapy (OMIT) products that embed food proteins to desensitize patients to food allergies, enabling daily administration during routine tooth brushing. The company is focused on creating a safe, disease-modifying treatment for food allergies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.